OOIR: Observatory of International Research

Papers

(The H4-Index of Allergology International is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Three-year prognoses after low-dose oral food challenge for cow's milk	101
Exacerbated signs of atopic dermatitis with gut dysbiosis predominate in male than in female adult patients	82
On non-biologic treatment clinical remission in adult-onset asthma: A 20-year cohort study in Taiwan	66
Efficacy and safety of systemic targeted therapies for atopic dermatitis in children: A systematic review and meta-analysis	62
Effects of raw seafood on the risk of hypersensitivity reaction recurrence in patients with an Anisakis allergy: A retrospective observational study in Japan	56
Clinical remission in severe asthma treated with biologics and macrolides: Definition, prevalence, associated factors, and future perspectives	55
Investigator-initiated, multi-center, single-arm, open-label study of the effectiveness of canakinumab in Japanese patients with Schnitzler syndrome	52
Analysis of drug-induced anaphylaxis cases using the Japanese Adverse Drug Event Report (JADER) database – secondary publication	50
Advantage of spirometry over oscillometry to detect dupilumab's effect on small airway dysfunction	45
A diagnostic score for eosinophilic granulomatosis with polyangiitis among eosinophilic disorders	42
High-dimensional immune profiling of atopic dermatitis reveals a dysfunctional OX40+ regulatory T cell subset	37
Hands at risk: Decoding clinical profiles and occupational causes in chronic hand eczema	35
Gut microbiota contributes to the maintenance of sublingually induced regulatory T cells and tolerance in mice	34
Urinary prostaglandin D2 metabolite as a potential diagnostic biomarker for perioperative anaphylaxis: A pilot study	32
IL-33-induced keratoconjunctivitis is mediated by group 2 innate lymphoid cells in mice	32
Topical application of activator protein-1 inhibitor T-5224 suppresses inflammation and improves skin barrier function in a murine atopic dermatitis-like dermatitis	32
Fibrin and fibrinogen degradation products/D-dimer ratio can be a useful marker for differentiating an acute attack of hereditary angioedema from thrombotic conditions	30
Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study	30
Factors contributing to the diagnosis and onset prediction of perennial allergic rhinitis in high-risk children: A sub-analysis of the CHIBA study	30
Exacerbation rates in Japanese patients with obstructive lung disease: A subanalysis of the prospective, observational NOVELTY study	29
A message from the new Editor-in-Chief	28
Filaggrin-deficient rats generated using zinc-finger nucleases spontaneously exhibit dry scaly skin	28
Urticaria and basophils	27
YTHDF1 regulates the proliferation and differentiation of keratinocytes via the PI3K/AKT signaling pathway in atopic dermatitis	27
The immune network across organs	27

Emerging cell and molecular targets for treating mucus hypersecretion in asthma	27
Mucus plugging on computed tomography and the sputum microbiome in patients with asthma, chronic obstructive pulmonary disease, and asthma-COPD overlap	26